We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Stress Shown to Cause Shift in Gene Products

By Biotechdaily staff writers
Posted on 20 May 2002
Stress can cause a shift in gene products (mRNAs) by altered splicing, the normal cut and paste mechanism that modifies mRNA, resulting in different proteins, according to a mouse study conducted by researchers at The Hebrew University of Jerusalem (Israel) and Ben-Gurion University (Be'er Sheva, Israel). More...
The finding was reported in the January 18, 2002, issue of Science.

The study revealed that stress causes changes in the splicing of many gene products, particularly in neurons, which has the result of modifying neuronal proteins. In particular, the ACHE gene, whose protein acetylcholinesterase helps control signaling across synapses, produces a normally rare mRNA following trauma. This mRNA produces an unusual variant of the acetylcholinesterase protein that cannot be integrated into synapses to assist transmission of nerve impulses.

The researchers measured the electrical activity in the brain of mice weeks after the mice were exposed to stress. They found much greater activity in the brains of stressed mice than in nonstressed mice. The researchers note that patients who receive drugs that affect their nervous system may eventually benefit from the recognition that stress renders them more sensitive to these drugs. The new findings suggest that altered mRNAs could be targets for a new class of drugs.

"Our study shows that stress initiates a series of events that includes changes in mRNA splicing and a consequent change of a key protein in neurons that results in an oversensitive electrical response,” said Prof. Hermona Soreq, who led the research team.




Related Links:
Hebrew University
Ben-Gurion Univ.

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.